Skip to main content

Vincerx Pharma (US:VINC) — Company Overview, News & Financial Data

Vincerx Pharma logo
VINCVincerx Pharma
Vincerx Pharma primary media
Company profile

Vincerx Pharma

Vincerx Pharma (NASDAQ:VINC) is a biopharmaceutical company focused on developing and commercializing transformative therapies for patients with cancer and other unmet medical needs. With a commitment to innovation, Vincerx Pharma is engaged in advancing a diverse pipeline of novel drug candidates, aiming to address the challenges associated with current treatments. The company's objective is to leverage its deep scientific expertise to bring forward new medicines that improve outcomes for patients facing life-threatening diseases. Through strategic collaborations and rigorous research, Vincerx Pharma strives to unlock new possibilities in care, emphasizing patient-centric solutions and breakthrough science.

Snapshot

Public USOwnership
2019Year founded
41Employees
Palo Alto, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
Palo Alto, US

Products and/or services of Vincerx Pharma

  • Bioconjugation platform for creating next-generation ADCs targeting cancer.
  • Lead candidate, VIP152, for CLL, B-cell malignancies, in clinical development phase.
  • VIP236, a small molecule drug conjugate targeting solid tumors, under investigation.
  • VIP943, an antibody targeting a novel undruggable cancer pathway, in preclinical stage.
  • VIP924, focused on addressing unmet needs in leukemia, early development stage.
  • Partnerships for advancing research in oncology and enhancing drug discovery pipeline.

Vincerx Pharma executive team

  • Dr. Raquel E. Izumi Ph.D.Co-Founder, Acting CEO, Secretary & Director
  • Mr. Tom C. Thomas J.D.Consultant
  • Mr. Alexander A. Seelenberger M.B.A.Consultant
  • Dr. John C. Byrd M.D.Founder & Chairman of Scientific Advisory Board
  • Mr. Kevin HaasActing CFO, VP of Finance & Corporate Controller
  • Dr. Hans-Georg Lerchen Ph.D.Chief Scientific Officer
  • Ms. Gabriela JairalaVP of Investor Relations & Corporate Communications and Chief of Staff
  • Ms. Karen Quarford M.B.A.Vice President of Quality Operations & Compliance
  • Ms. Melissa Merrick SPHRSenior Director of People & Culture and Head of Human Resource
  • Dr. Beatrix Stelte-Ludwig Ph.D.Executive Chief Development Officer